...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D
04/24/17
> Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study
04/20/17
> Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech
04/19/17
> RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®
04/18/17
> Agendia Appoints Patrick J. Balthrop Sr., Former CEO of Luminex, as Chairman
04/12/17
> LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program
04/11/17
> LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay
04/11/17
> Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor
04/06/17
> RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam®
04/05/17
> RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma
04/04/17
> NBE-Therapeutics Expands Board of Directors by the Appointment of Hans-Peter Gerber
04/04/17
> Australia’s Bionic Vision Technologies Raises USD18 Million (AUD23.5 M) to Develop ‘Bionic Eye’ for Global Markets
04/03/17
> Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study
04/03/17
> Calypso Biotech Licenses CALY-001 Best-In-Class Anti-MMP-9 Antibody to EA Pharma
03/31/17
> Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board
03/28/17
> Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24
03/28/17
> Chemotherapy as a Tablet Instead of an Intravenous Infusion: A Benefit for the Patient
03/27/17
> RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease
03/21/17
> European Group on Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint® Test with Highest Level 1A Clinical Evidence
03/21/17
> Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
03/17/17
> Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management
03/17/17
> Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval
03/14/17
> Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017
03/13/17
> German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence
03/08/17
> Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech
03/06/17
> Apollo Therapeutics: Funding of Four Initial Projects and Operational Update
02/22/17
> AmpTec and CMC Pharma Close Consulting Agreement about API-mRNA Production for IND/CTA Use in Early Phase Clinical Studies
02/21/17
> CellGenix Headquarters Expands to Meet the Increasing Demands for GMP Cell Culture Reagents
02/21/17
> Sartorius Enters Into a Corporate Partnership Program with the European Molecular Biology Laboratory (EMBL)
02/17/17
> Polyganics’ “STOP NEUROMA” Study Interim Data Shows Reduction in Pain
02/16/17
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 47